Skip to main content
. Author manuscript; available in PMC: 2022 Mar 29.
Published in final edited form as: J Vasc Surg. 2021 Sep 8;75(2):515–525. doi: 10.1016/j.jvs.2021.08.060

Table II.

Baseline characteristics for female and male patients undergoing AAA repair stratified by intact and rupture repair

Female Male P value

Intact repair
 No. patients 10,118 41,018
 Diameter, cm 5.4 5.0–5.9 5.5 5.1–6.0 <.001
 ASI, cm/m2 3.1 2.8–3.5 2.7 2.4–3.1 <.001
 AHI, cm/m 3.3 3.1–3.6 3.1 2.9–3.5 <.001
 BSA, m2 1.7 1.6–1.9 2.0 1.9–2.2 <.001
 Height, m 1.6 1.6–1.7 1.7 1.7–1.8 <.001
 EVAR 7893 78 34,643 85 <.001
 Age, y 75 69–80 73 67–79 <.001
 Race/ethnicity <.001
  Non-Hispanic white 8768 89 36,588 92
  Black or African American 710 7.2 1570 3.9
  Hispanic 249 2.5 1094 2.7
  Asian 101 1.0 535 1.3
  Other 44 0.5 151 0.4
 Underweight 539 5.3 728 1.8 <.001
 Obese 2957 29 12,922 32 <.001
 Current smoker 3665 36 13,008 32 <.001
 Hypertension 8605 85 34,170 83 <.001
 Insulin-dependent diabetes 322 3.2 1474 3.6 .045
 Coronary artery disease 3176 31 18,204 44 <.001
 CHF <.001
  None 9070 90 36,196 88
  Asymptomatic/mild 914 9.0 4141 10
  Moderate/severe 130 1.3 660 1.6
 COPD 4203 42 12,920 32 <.001
 CKD 609 6.1 1462 3.6 <.001
 Prior aortic aneurysm repair 322 3.2 1428 3.5 .14
 Family history of AAA 1048 10 3575 8.8 <.001
 Preoperative ASA/aspirin use 6284 62 27,526 67 <.001
 Preoperative beta-blocker use 5626 56 23,178 57 .10
 Preoperative statin use 6847 68 29,704 72 <.001
 Rupture repair
  No. patients 978 3533
  Diameter, cm 6.7 5.7–7.8 7.7 6.4–9.0 <.001
  ASI, cm/m2 3.8 3.2–4.5 3.7 3.1–4.4 .030
  AHI, cm/m 4.1 3.6–4.8 4.3 3.6–5.1 <.001
  BSA, m2 1.7 1.6–1.9 2.0 1.9–2.2 <.001
  Height, m 1.6 1.5–1.7 1.8 1.7–1.9 <.001
  EVAR 562 58 2097 60 .29
  Age, y 76 70–83 72 65–78 <.001
 Race/ethnicity .001
  Non-Hispanic white 834 88 3075 90
  Black or African American 80 8.5 184 5.4
  Hispanic 23 2.4 97 2.8
  Asian 6 0.6 55 1.6
  Other 3 0.3 7 0.2
 Underweight 73 7.5 102 2.9 <.001
 Obese 320 33 1187 34 .61
 Current smoker 409 42 1619 46 .019
 Hypertension 784 80 2730 78 .068
 Insulin-dependent diabetes 35 3.6 117 3.3 .69
 Coronary artery disease 236 24 1132 32 <.001
 CHF .18
  Asymptomatic/mild 91 9.4 314 9.0
  Moderate/severe 26 2.7 62 1.8
 COPD 361 37 999 29 <.001
 CKD 171 18 418 12 <.001
 Prior aortic aneurysm repair 47 4.8 232 6.6 .041
 Family history of AAA 58 6.1 200 5.8 .78
 Preoperative ASA/aspirin use 356 37 1412 41 .054
 Preoperative beta-blocker use 388 40 1345 39 .31
 Preoperative statin use 406 42 1518 44 .46

AAA, Abdominal aortic aneurysm; AHI, aortic height index; ASA, acetylsalicylic acid; ASI, aortic size index; BSA, bodysurface area; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; EVAR, endovascular aneurysm repair; Obese, body mass index of 30 or above; Underweight, body mass index below 18.5.

Categorical variables are presented as number (%) and continuous variables as median (interquartile range).